Mangoceuticals gets Nasdaq extension until Feb. 1, 2027 to regain $1 bid compliance

The company said the additional 180-day window comes as it pursues a business combination with Nuclea Energy and may use a reverse stock split if needed.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.